mFOLFOX6-Cetuximab/Encorafenib Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of a modified version of the FOLFOX6 regimen (mFOLFOX6), which contains leucovorin, continuous infusional fluorouracil, and oxaliplatin, in combination with cetuximab and encorafenib that can be used for the treatment of colorectal cancer.

**Synonyms:** - Braftovi-Erbitux-mFOLFOX6 - Cetuximab-Encorafenib-mFOLFOX-6 - Cetuximab-Encorafenib-mFOLFOX6 - Cetuximab/Encorafenib/Modified Fluorouracil/Leucovorin/Oxaliplatin - Cetuximab/Encorafenib/mFOLFOX6 - Encorafenib/Cetuximab-mFOLFOX6 - Encorafenib/Cetuximab/mFOLFOX6 - Modified FOLFOX-6 Plus Cetuximab/Encorafenib - Modified FOLFOX6-Braftovi-Erbitux - Modified Fluorouracil Continuous Infusion/Leucovorin/Oxaliplatin Plus Encorafenib/Cetuximab - Modified Leucovorin/Fluorouracil/Oxaliplatin Plus Cetuximab/Encorafenib - Modified Leucovorin/Fluorouracil/Oxaliplatin/Encorafenib/Cetuximab - mFOLFOX-6-Cetuximab-Encorafenib - mFOLFOX6 Plus Cetuximab/Encorafenib - mFOLFOX6-Cetuximab-Encorafenib - mFOLFOX6-Encorafenib-Cetuximab - mFOLFOX6/Erbitux/Braftovi